Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Study of Blood Levels of Ceftaroline Fosamil in Children Who Are Receiving Antibiotic Therapy in the Hospital

ClinicalTrials.gov ID: NCT01298843

Public ClinicalTrials.gov record NCT01298843. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pharmacokinetics of a Single Dose of Ceftaroline Fosamil in Children Ages Birth to Younger Than 12 Years With Suspected or Confirmed Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess blood levels of Ceftaroline fosamil in children.

Study identification

NCT ID
NCT01298843
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Forest Laboratories
Industry
Enrollment
53 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
Up to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2011 (Type not available)
Primary completion
Feb 2013 (Actual)
Completion
Feb 2013 (Actual)
Last update posted
May 14, 2014

2011 – 2013

United States locations

U.S. sites
15
U.S. states
11
U.S. cities
14
Facility City State ZIP Site status
Investigational Site Phoenix Arizona 85008 —
Investigational Site Little Rock Arkansas 72202 —
Investigational Site Orange California 92868 —
Investigational Site San Diego California 92123 —
Investigational Site Indianapolis Indiana 46202 —
Investigational Site Louisville Kentucky 40202 —
Investigational Site Shreveport Louisiana 71113 —
Investigational Site Jackson Mississippi 39216 —
Investigational Site Omaha Nebraska 68198 —
Investigational Site Akron Ohio 44308 —
Investigational Site Cleveland Ohio 44106 —
Investigational Site Cleveland Ohio 44109 —
Investigational site Toledo Ohio 43606 —
Investigational Site Forth Worth Texas 76102 —
Investigational Site Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01298843, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2014 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01298843 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →